Navigation Links
University of Alberta researchers report breakthrough in lowering bad cholesterol, fatty acid levels
Date:1/10/2008

There is heartening news out of the University of Alberta for those who may have overindulged during the recent holidays.

U of A medical researchers have found a way to reduce the amount of bad cholesterol and fatty acids that end up in the blood from food the body metabolizes, a key discovery that could lead to new drugs to treat and reverse the effects of Type 2 diabetes and heart disease related to obesity.

In a series of recently published articles,* Dr. Richard Lehner and his colleagues report they successfully decreased the level of LDL (low-density lipids) the so-called bad cholesterol in the blood of mice and hamsters by manipulating a particular enzyme.

Its well-known that eating too much fat and sugar and too little exercise will make you fat, and that obesity often leads to diabetes and heart disease. Lehners group studied the mechanisms behind this.

We established the proof of principle of how these metabolic pathways work, he says. We discovered the activity of an enzyme that releases fatty acids from fat cells and the liver into the blood and how to inhibit this from happening.

Drugs called statins are used to lower LDL levels in patients, but do not treat obesity. What makes the U of A researchers findings noteworthy is their discovery of how to inhibit LDL and triglycerides, which are another form of fat in the blood and a leading risk in obesity-related Type 2 diabetes as well as heart disease.

Lehner is director of the Group on Molecular and Cell Biology of Lipids in the U of As Faculty of Medicine and Dentistry. The research is being supported by the Canadian Institutes of Health Research and the Heart and Stroke Foundation.

Lehner is also a senior scholar for the Alberta Heritage Foundation for Medical Research.

There is a substantial pharmacological interest in the enzymes that control TG (triglycerides fatty acids) and cholesterol metabolism in tissue
'/>"/>

Contact: Julia Necheff
julia.necheff@ualberta.ca
780-492-0437
University of Alberta
Source:Eurekalert

2

GOOD

Page: 1 2

Related biology news :

1. A study by the MUHC and McGill University opens a new door to understanding cancer
2. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
3. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
4. Bioengineers at University of Pennsylvania devise nanoscale system to measure cellular forces
5. Binghamton University researchers investigate evolving malaria resistance
6. Antioxidant to retard wrinkles discovered by Hebrew University researcher
7. Society for General Microbiology 161st Meeting, University of Edinburgh
8. Boston University biomedical engineers find chink in bacterias armor
9. KAUST and American University in Cairo to collaborate on research and academic development
10. UNH becomes first university in nation to use landfill gas as primary energy source
11. University of Minnesota study refutes belief that black men have more aggressive prostate cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...s that a common oral bacterium may exacerbate auto...al, "Unique Lipids from a Common Human Bacterium R...hancing Autoimmunity," appears in the December 200... Multiple sclerosis (MS), a disease where the imm...cts nearly 1 in 700 people in the United States. ...
(Date:11/23/2009)...ailable for the H1N1 virus has been sent to vaccin...ination marks the first time vaccine has been sent..., Iowa State University,s Hank Harris, professor ...er and has been shipping preventive doses to swine...l weeks., The latest vaccines were shipped to a ...
(Date:11/23/2009)...E and USDA study concluded that 50 million U.S. ac...re could be converted from current uses to the pro... from which biomass could be harvested for use as ...n of a perennial grass monoculture from which subs... is expected to require nitrogen fertilizer. , A...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2Child Care Centers Throughout Mexico Being Crucified Unjustly Says Interchildren Inc 52045 1Child Care Centers Throughout Mexico Being Crucified Unjustly Says Interchildren Inc 52045 2Senators Baucus and Grassley Statement Regarding Physician Hospitals Despicable 52040 1Covanta Mendota Recognized for Its Exemplary Health and Safety Practices 52036 1Covanta Mendota Recognized for Its Exemplary Health and Safety Practices 52036 2Covanta Mendota Recognized for Its Exemplary Health and Safety Practices 52036 3
...CMay 28, 2008The 2008 American Society for Microbi...nvestigator Award is being presented to Adrian M. ...nfectious Diseases, NIAID, National Institutes of ...plied research in clinical microbiology or antimic...work studying infection susceptibility and resista...
...Man international scientific and professional orga...promoting the practical applications, technology a...nehas awarded $300,000 in research grants to suppo...ed by SNM,s Education and Research Foundation, rep...ular imaging and therapy by supporting the next ge...
..., R.I. July 14, 2008 The outlook for air quality... there,s little that the Chinese government can do... University of Rhode Island atmospheric chemist wh...the last five years by Chinese scientists. , "Th...nent to the pollutants that cause unhealthy air in...
Other Biology News:SNM awards $300,000 to support molecular imaging research 2URI researcher: China can't fully fix air quality problem for Olympics 2
(Date:11/24/2009)..., , ST. LOUIS, Nov. 24 /PRNewswire-First...) will be presenting at the NASDAQ OMX conference ... 7:45 AM US/CST. Interested parties may listen via...at http://inve s tor.sig m a a ldrich.com/...this file. ,, About Sigma-Aldrich: Sigma-...
(Date:11/24/2009)..., , SHANGHAI, Nov. 24 /PRNewswire-...ate Food & Drug Administration (SFDA) has appr...) for its oral insulin project,(Nodlin), an innova...ND,approval allows Biolaxy to initiate its first p...sorder characteristic of high blood glucose and po...
(Date:11/24/2009)..., , DUBLIN, November 24 /PRNewswire-Fi... the global specialty biopharmaceutical company, t...European Medicines Agency for,velaglucerase alfa, ...pment,for the treatment of Type 1 Gaucher disease....lucerase alfa that has been submitted, with previo...
(Date:11/24/2009)... Chemical Abstracts Servic..., reports that China,s patent office is now the wo...tions in chemistry. China trailed Japan,s patent o...n (WIPO), and the United States Patent and Tradema...ed the USPTO in 2005, WIPO in 2006, and exceeded J...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
... To date, 60 specialty & fine,chemical and custom ...duled,to exhibit at the Pharma ChemOutsourcing Con...y., The conference and exhibition has already att...t September. The supplier community is attracted t...gh ratio of attendees from,pharmaceutical and biop...
...n by Dr. John St. John -, - Three Poster Present... ADDISON, Texas, May 28 ULURU Inc. (Amex: ULU ),...materials Congress, to be,held in Amsterdam from M...s,Vice President of Material Science, will give an...tion of three posters., The title of the invited ...
...ve Three Oncology Products in Clinic -, - Lead Ca...n-Small Cell Lung Canc...y 28th, at 11:00 a.m. Pacific ...y 28 /PRNewswire-FirstCall/ - Sonus,Pharmaceutical...s Inc., a,privately held biopharmaceutical develop...
Other Biology Technology:60 Specialty Chemical, Fine Chemical & Custom Synthesis Providers Will Exhibit at Pharma ChemOutsourcing on September 8-9 in New Jersey 2ULURU Inc. to Present at the 8th World Biomaterials Congress 2ULURU Inc. to Present at the 8th World Biomaterials Congress 3Sonus Pharmaceuticals and OncoGenex Technologies to Merge 2Sonus Pharmaceuticals and OncoGenex Technologies to Merge 3Sonus Pharmaceuticals and OncoGenex Technologies to Merge 4Sonus Pharmaceuticals and OncoGenex Technologies to Merge 5Sonus Pharmaceuticals and OncoGenex Technologies to Merge 6Sonus Pharmaceuticals and OncoGenex Technologies to Merge 7Sonus Pharmaceuticals and OncoGenex Technologies to Merge 8
Silencer Pre-designed siRNA, PAGE purified, annealed from Ambion
Custom siRNA, standard purity, annealed from Ambion
...ed to rapidly and reliably amplify unknown genomic...rovides hassle-free, ready-to use components, at a... ingredients are provided in each kit. The Genome ... cloning of genomic DNA, isolating promoter and re...
Bis-acrylamide, Ultra Pure from Research Organics, Inc.
Biology Products: